|
Market Closed -
NYSE
04:00:03 2026-09-15 pm EDT
|
5-day change | 1st Jan Change | ||
| 161.85 USD | -1.18% |
|
+1.13% | +76.06% |
| 01:00am | AlphaValue/Baader Europe Notes GSK's Plans to Address Upcoming Patent Cliff; Price Target Down | MT |
| Sep. 15 | Guardant Health Could Benefit From AstraZeneca Trial Failure, UBS Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,013B | |||||
| 644B | - | ||||
| 465B | |||||
| 352B | |||||
| 264B |
Select your edition
All financial news and data tailored to specific country editions
